University of Melbourne
Study examined cardiac actions of urotensin II
Published in Biotech Law Weekly, August 26th, 2005
Scientists in Australia report, "Urotensin II (UII) is a highly conserved peptide that has potent cardiovascular actions following central and systemic administration. To determine whether the cardiovascular actions of UII are mediated via beta-adrenoceptors, we examined the effect of intravenous (IV) propranolol on the responses to intracerebroventricular (ICV) and IV administration of UII in conscious sheep."
S.G. Hood and colleagues of the University of Melbourne explained, "Sheep were surgically instrumented with ICV guide tubes and flow probes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2005-08-26)
More Articles from Biotech Law Weekly
- Abbott Laboratories
Pharma firm reaches agreement with Brazilian government for AIDS drug - BSD Medical Corp.
Patent to be issued for new device to optimize radiation treatments - CryoLife, Inc.
Biomaterials company to settle shareholder suits - Cyberonics, Inc.
VNS maker announces revised long-term sales outlook and guidance for fiscal 2006 - CytoGenix, Inc.
Company files U.S. patent application for family of DNA antimicrobial agents - DNAPrint genomics, Inc.
Genomics company launches new corporate marketing and product branding campaign - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
